A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Fexofenadine Impurity 28 - Request Quote

Picture of Fexofenadine  Impurity 28

Fexofenadine Impurity 28

SZ CAT No:SZ-F026052
CAS No
NA
Mol.F.
C24H26O2
Mol.Wt.
346.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Fexofenadine Impurity 28 is chemically ((2-Methylpropane-1,1-diyl)bis(4,1-phenylene))bis(cyclopropylmethanone). Fexofenadine Impurity 28 is supplied with detailed characterization data compliant with regulatory guideline. Fexofenadine Impurity 28 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Fexofenadine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Fexofenadine Impurity 28

Purchase Fexofenadine Impurity 28

Fexofenadine Impurity 28 suppliers

Fexofenadine Impurity 28 manufacturers

Fexofenadine Impurity 28 price

Order Fexofenadine Impurity 28

Enquire Fexofenadine Impurity 28

Fexofenadine Impurity 28 cost

Fexofenadine Impurity 28 Supplier

Fexofenadine Impurity 28 Distributor

Fexofenadine Impurity 28 for Method Validation

Fexofenadine Reference Standard

Fexofenadine Impurity 28 for ANDA Filing

Fexofenadine Impurity 28 for Forced Degradation Studies

Fexofenadine Impurity 28 Identification Standards

Fexofenadine Impurity 28 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,